Stay updated on Nanogold for Remyelination in MS Clinical Trial
Sign up to get notified when there's something new on the Nanogold for Remyelination in MS Clinical Trial page.

Latest updates to the Nanogold for Remyelination in MS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice explains the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now shows a new revision entry v3.7.0, indicating a new published version of the page. The older revision v3.6.6 is removed from the current history listing.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record history now shows a new version entry on 2026-08-26 with revision v3.6.6 and added sections such as Adverse Events, Baseline Characteristics, Participant Flow, and Outcome Measures, replacing the previous v3.6.5.SummaryDifference2%

- Check95 days agoChange DetectedThe history now includes a 'Results Submitted' entry and updates the revision to v3.6.5, replacing the earlier 'No Results Posted' and v3.6.4 entries. This indicates the study results have been submitted and the record has been updated to the latest version.SummaryDifference0.2%

Stay in the know with updates to Nanogold for Remyelination in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nanogold for Remyelination in MS Clinical Trial page.